SCHEMBL9708515

SCHEMBL9708515

CC(C)Cn1c(=O)n(C)c(=O)c2c1nc(CC(C)(C)C)n2Cc1ccc(-c2ccccc2)c(-c2nnn[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 1/20 0.42
PDE1B Q01064 1/20 0.42
PDE1C Q14123 1/20 0.42
NPSR1 Q6W5P4 5/20 0.40
TSHR P16473 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.40
CASP1 P29466 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HTT P42858 2/20 0.40
CASP7 P55210 1/20 0.40
HPGD P15428 1/20 0.38
ALOX15 P16050 2/20 0.38
ALDH1A1 P00352 6/20 0.38
TP53 P04637 1/20 0.38
USP2 O75604 1/20 0.37
PDE5A O76074 3/20 0.36
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9709079 0.92 PDE1A (0.43) PDE1APDE1BPDE1CNPSR1TSHR
SCHEMBL9708162 0.85 RAB9A (0.42) PDE1APDE1BPDE1CNPSR1TSHR
SCHEMBL9708158 0.85 ADORA3 (0.41) PDE1APDE1BPDE1CADORA2AADORA2B
SCHEMBL9708074 0.85 ADORA1 (0.38) ADORA2AADORA2BADORA3ADORA1
SCHEMBL9708448 0.84 ADORA3 (0.40) ADORA2AADORA2BADORA3ADORA1
SCHEMBL9708150 0.84 AGTR1 (0.36) PDE1APDE1BPDE1CALDH1A1ADORA2A
SCHEMBL9707973 0.83 ADORA1 (0.42) NPSR1TSHRSMN1; SMN2LMNACASP1
SCHEMBL9707475 0.83 ALOX15 (0.41) NPSR1TSHRSMN1; SMN2HSD17B10HTT
SCHEMBL9707553 0.83 PDE1A (0.43) PDE1APDE1BPDE1CNPSR1TSHR
SCHEMBL9708090 0.83 ADORA3 (0.39) ADORA2AADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed